C

아이센스

099190KOSDAQ

51.0 / 100

Reference Date: 2026-10-23

Financial Score19.5 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly up 1.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Ai-Sensor is a company that develops, manufactures, and sells medical sensors and diagnostic equipment based on electrochemical and biosensor technologies. Its main business segments include blood glucose meters and point-of-care testing (POCT) devices. The blood glucose meter segment offers products with high accuracy and precision, while the CareSens Air continuous glucose monitoring system stands out with a competitive MARD value of 9%. The POCT segment provides a range of medical equipment, including electrolyte/gas analyzers and coagulation measurement devices.

Number of Employees

957people

Average Salary

55.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
1.41Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE
-1.96Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
21.41Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲9.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲60.5% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -0.5% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (11%, downtrend)

Current 16,150Won52-week high 27,00052-week low 14,690
1-month return3.0Point

1m 1.06% (flat)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-10-01